With profit as the most obvious motive, psychiatry is pushing dangerous psychedelic drugs at every turn. New research studies ...

Professor Joanna Moncrieff’s new book Chemically Unbalanced further calls for greater patient consent provisions to inform ...

“The experience was so powerful that we felt compelled to help support the legal development of psychedelic-assisted ...

Greek authorities say they have dismantled a criminal network accused of exploiting migrant health care identification numbers to illegally distribute psychiatric medications and other prescription dr ...

Johnson & Johnson surpasses expectations with robust fourth-quarter profits, backed by its acquisition of Intra-Cellular and ...

Atai Life Sciences N.V. reported positive top-line phase 2a results of BPL-003 in treating Alcohol Use Disorder patients.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Johnson & Johnson reported higher-than-expected fourth-quarter revenues, driven by strong cancer drug sales, amidst its ...

Patients with atopic dermatitis using dupilumab vs conventional drugs had less risk for psychiatric and sleep disorders.